However, this method’s limitations include a high rate of false positives and overdiagnosis, often leading to unnecessary overtreatment, as benign conditions like prostatic hyperplasia can cause elevated PSA levels [2]. This evidence concerns the gene KLK3 and benign prostatic hyperplasia.